NCT03202316 2025-12-16Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting37 enrolled